Genetic Model for the Rh Blood-Group System (Conjugated Operons/Repressors/Quantitative Blood Typing) RICHARD E

Total Page:16

File Type:pdf, Size:1020Kb

Genetic Model for the Rh Blood-Group System (Conjugated Operons/Repressors/Quantitative Blood Typing) RICHARD E Proc. Nat. Acad. Sci. USA Vol. 70, No. 5, pp. 1303-1307, May 1973 Genetic Model for the Rh Blood-Group System (conjugated operons/repressors/quantitative blood typing) RICHARD E. ROSENFIELD*, FRED H. ALLEN, JR.t, AND PABLO RUBINSTEIN*t *Department of Pathology, Mount Sinai School of Medicine, 5th Ave. and 100th Street, New York, N.Y. 10029; tNew York Blood Center, 310 East 67th Street, New York, N.Y. 10021 Communicated by P. Levine, February 26, 1173 ABSTRACT Inherited quantitative aspects of the Rh No such studies have been possible with membrane anti- blood-group system and susceptibility of Rh to the effects gens, perhaps because their actual isolation from lipid mem- of independently segregating suppressor genes can be cause serious accounted for with a conjugated operon model. This brane constituents might degradation (17). assumes the existence of four operator or promotor (con- Recent studies of the microstructure of human erythrocyte trol) genes for these functions, while closely linked struc- membranes revealed moveable protein particles embedded in tural regions determine the qualitative characteristics of the lipid phase (18); they were associated with blood-group A Rh antigens. Observed restriction of antigenic crossre- activity (18) and with receptors for both phytohemagglutinin activity to the products of adjacent genetic regions and data from blood typing of nonhuman primates both and influenza virus (19). The number of these particles was suggest that Rh complexity arose from a series of gene estimated to be 4200 (18)-4500 (19) per /Am2 of the surface of duplications and independent mutations. erythrocyte ghosts or about 6 X 105 for an average intact cell. The 33 qualitatively different antigenic specificities of the Rh Membrane protein particles are likely to consist of several blood-group system (1, 2) have become extraordinarily dif- polypeptides, some of which may be wholely or partly re- ficult to organize systematically. Each allele at the Rh locus sponsible for the expression of blood-group antigens. If such a determines a variable number of different antigens (3, 4), and polypeptide were directly determined by a single blood-group recombination has been observed in just one family (5). In gene, alloantigenic variation could be the result of single addition, quantitative differences in the expression of Rh anti- amino-acid substitutions similar to the situation for Gml of gens are also under the control of Rh genes (6). Accommoda- IgG heavy chains (20). However, tertiary structures arising tion of quantitative data by genetic theories devised to ac- from interaction between a polypeptide and either other poly- count only for qualitative alloantigenic variants (3, 4, 7, 8) peptides or other membrane structures could also give rise to results in a vast increase in an already overwhelmingly large blood-group antigens. For instance, Rh antigenic activity was number of complex alleles. lost when ghosts were extracted with lipid solvents, but Rh In this report, Rh data have been arranged in a manner that distinguishes qualitative from quantitative information. From this arrangement, a consistent genetic model emerges that may TABLE 1. Glossary of Rh terminology* provide a biologically sounder conceptual basis for this com- (refs. 26 and 27, text) plex system. In the Rh system (see Table 1 for glossary of terms) Rh: wl - 12 - rhG or G 23 - Dw (Rh or DU) was the first quantitative variant found (9). I Rho or D A most interesting situation was shown to involve allelic 2 - rhI or C 13 a RhA 24 w ET interaction, with the R-",2 -3 (r' or dCe) gene being suppres- 3 - rh" or E 14 - RhB 26 a Deal sive of RI alleles (R or D) in trans position (10). Quantitative 4 a hr' or c 15 - RhC 27 - cis cE variants of RI were documented quantitatively by Silber et 5 - hr" or e 16 n Rh0 28 - hrH al. (11) and Masouredis (12), but Gibbs and Rosenfield (6) 6 a hr or f or cis ce 17 a Hr0 29 - 'total Rh' found that the quantitative "degree of expression" was under 7 - hr1 or cis Ce 18 a Hr 30 u Goa the strict genetic control of Rh genes and so was the inter- 19 a hrs 31 - hrB allelic depressive effect of R-1"2 -3. Within an extensive pedi- 8 - rhWl or CW gree, identical genotypes were quantitatively identical for 9 - rhX or CX 20 a VS 32 a determined by RN four different Rh antigens, whereas qualitatively similar geno- 10 = hrt or V or eS 21 a CG 33 - determined by R0 Har types in the general population varied over a significant range 11 - rht or Ew 22 a cia CE 34 a Bas. (6). Using a different method, Berkman et al. (13) con- firmed these observations and extended the findings to the * Antigens shown as "Rh" followed by corresponding number. other blood groups. Phenotypes shown as "Rh: " followed by numbered antigens Studies of the chemistry of secreted human blood-group separated by commas for which tests were performed. Negative substances have provided detailed insight into the chemical or weak result of test shown by minus (-) or "w," respectively, of and Lewis antigens (14, 15), while evalua- preceding number. Alleles shown by R with antigens produced genetics ABO, H, or not produced given as for phenotype but in superscript. Rh25 tion of N-acetyl-galactosaminyl transferases established both (LW) is the main antigen shared by human and rhesus eryth- the nature and the mechanism of production of quantitative rocytes. In man Rh25 is determined by genes that segregate variants of the A antigen through the Km value of the specific independently of the Rh locus. Rh34 has been assigned to the transferase (16). specificity of the total immune response of Mrs. Bas (32). 1303 Downloaded by guest on September 25, 2021 1304 Genetics: Rosenfield et al. Proc. Nat. Acad. Sci. USA 70 (1973) activity of ghosts treated with n-butanol was restored by gens are expressed, while XQ/XQ depresses slightly less and addition of "nonspecific" phosphatidyl choline (21). In- produces "pseudo rhG" (34). Furthermore, all known ex- terestingly, F. A. Green found that Rh.,,1 cells reported in amples of either blood type are associated with congenital ref. 22 were neither deficient in "restorative" phosphatidyl hemolytic anemia characterized by cup-shaped erythrocytes choline nor could their ghosts be rendered Rh-antigenic by (stomatocytes) rather than normal discoid erythrocytes (35, addition of n-butanol extracts of normal cells (personal com- 36). Rhnull also arises from the homozygous state of "amor- munication to R.E.R.). Tertiary structure interactions appear phic" Rh genes (r or -) (37), and this, too, is associated with to underly the HI and AI determinants (3) and may explain stomatocytic hemolytic anemia (38). Thus, one adequately (see Rh25 of Table 1) the phenotypic association between Rh functioning Rh gene appears to be needed for production of and LW (3, 23). normal erythrocyte membranes. Whether the erythrocyte Strongly suggestive evidence that Rh is protein in nature changes associated with RhnuiI and "pseudo rhG" are a direct (24) includes its reversible inactivation by p-chloromercuri- consequence of the altered expression of Rh antigens or the benzoate (25), inactivation by N-ethylmaleimide (25), de- result of an epistatic effect of Rh genes is as yet unknown. struction by heating to 56' (26), susceptibility to proteolytic The expression of all Rh antigens from one Rh gene can be digestion (27), and denaturation by urea (25, 28) or exposure depressed by certain paired genes, especially those determin- to pH 3.0 (29). The role of phosphatidyl choline and the high ing Rh2 (rh' or C) (6). This effect, too, is more readily com- lability of Rh indicate that the tertiary structure of a protein- prehensible when a main point of regulation is assumed. lipid complex is essential to the formation, orientation, and/or The main regulatory locus of Rh may display allelic alterna- stabilization of the expression of Rh determinants. tives. If R29 is considered the "normal" allele, R-29 can be Table 1 gives the 33 antigenic specificities described in the assumed for cis Rhnun1 and RI' can be used for an abnormal Rh system. The genetics of Rh, however, is far more com- expression of all structurally specified antigens with coinciden- plicated because the qualitative combination of antigens tal emergence of a rare and otherwise unobserved antigen, within each allotype and the degree to which each antigen is Rh33 (39). These allelic possibilities, however, are not obliga- expressed are both under the control of the Rh locus. In fact, tory because similar effects would obtain with selected cis to account for the thousands of resulting Rh allotypes, no less conditions at other regions of the Rh system. These and other than four conjugated and coordinated systems, or operons problems relating to the main point of regulation will be con- (30), appear to be needed on chromosome 1 (31). This is shown sidered later. in Fig. 1. The serology of the Rh blood-group system can be divided A main point of regulation, although not an absolute neces- into two parts, one concerning Rhl (Rh. or D) and the other sity, clearly indicates how all of Rh is susceptible to suppres- non-Rhl antigenic specificities. Indeed, this is the basis of sion, especially by independently segregating, partially reces- Wiener's Rh-Hr terminology (4). However, Rhl is not likely sive genes. The known independent suppressors are called to be a discrete antigenic determinant but, rather, a series of X~r (33) and XQ (34) although neither is associated with the distinct antigens inherited en bloc and all determined by X chromosome.
Recommended publications
  • Journal of Blood Group Serology and Molecular Genetics Volume 34, Number 1, 2018 CONTENTS
    Journal of Blood Group Serology and Molecular Genetics VOLUME 34, N UMBER 1, 2018 This issue of Immunohematology is supported by a contribution from Grifols Diagnostics Solutions, Inc. Dedicated to advancement and education in molecular and serologic immunohematology Immunohematology Journal of Blood Group Serology and Molecular Genetics Volume 34, Number 1, 2018 CONTENTS S EROLOGIC M ETHOD R EVIEW 1 Warm autoadsorption using ZZAP F.M. Tsimba-Chitsva, A. Caballero, and B. Svatora R EVIEW 4 Proceedings from the International Society of Blood Transfusion Working Party on Immunohaematology Workshop on the Clinical Significance of Red Blood Cell Alloantibodies, Friday, September 2, 2016, Dubai A brief overview of clinical significance of blood group antibodies M.J. Gandhi, D.M. Strong, B.I. Whitaker, and E. Petrisli C A S E R EPORT 7 Management of pregnancy sensitized with anti-Inb with monocyte monolayer assay and maternal blood donation R. Shree, K.K. Ma, L.S. Er and M. Delaney R EVIEW 11 Proceedings from the International Society of Blood Transfusion Working Party on Immunohaematology Workshop on the Clinical Significance of Red Blood Cell Alloantibodies, Friday, September 2, 2016, Dubai A review of in vitro methods to predict the clinical significance of red blood cell alloantibodies S.J. Nance S EROLOGIC M ETHOD R EVIEW 16 Recovery of autologous sickle cells by hypotonic wash E. Wilson, K. Kezeor, and M. Crosby TO THE E DITOR 19 The devil is in the details: retention of recipient group A type 5 years after a successful allogeneic bone marrow transplant from a group O donor L.L.W.
    [Show full text]
  • Introduction to the Rh Blood Group.Pdf
    Introduction to the Rhesus Blood Group Justin R. Rhees, M.S., MLS(ASCP)CM, SBBCM University of Utah Department of Pathology Medical Laboratory Science Program Objectives 1. Describe the major Rhesus (Rh) blood group antigens in terms of biochemical structure and inheritance. 2. Describe the characteristics of Rh antibodies. 3. Translate the five major Rh antigens, genotypes, and haplotypes from Fisher-Race to Wiener nomenclature. 4. State the purpose of Fisher-Race, Wiener, Rosenfield, and ISBT nomenclatures. Background . How did this blood group get its name? . 1937 Mrs. Seno; Bellevue hospital . Unknown antibody, unrelated to ABO . Philip Levine tested her serum against 54 ABO-compatible blood samples: only 13 were compatible. Rhesus (Rh) blood group 1930s several cases of Hemolytic of the Fetus and Newborn (HDFN) published. Hemolytic transfusion reactions (HTR) were observed in ABO- compatible transfusions. In search of more blood groups, Landsteiner and Wiener immunized rabbits with the Rhesus macaque blood of the Rhesus monkeys. Rhesus (Rh) blood group 1940 Landsteiner and Wiener reported an antibody that reacted with about 85% of human red cell samples. It was supposed that anti-Rh was the specificity causing the “intragroup” incompatibilities observed. 1941 Levine found in over 90% of erythroblastosis fetalis cases, the mother was Rh-negative and the father was Rh-positive. Rhesus macaque Rhesus (Rh) blood group Human anti-Rh and animal anti- Rh are not the same. However, “Rh” was embedded into blood group antigen terminology. The
    [Show full text]
  • Safe Blood and Blood Products
    Safe Blood and Blood Products Module 3 Blood Group Serology Safe Blood and Blood Products Module 3 Blood Group Serology Conversion of electronic files for the website edition was supported by Cooperative Agreement Number PS001426 from the Centers for Disease Control and Prevention (CDC), Atlanta, United States of America. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of CDC. © World Health Organization, reprinted 2009 All rights reserved. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; e-mail: [email protected]). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.
    [Show full text]
  • Volume 27, Number 4, 2011
    John J. Moulds mcmxliii–mmxi VOLUME 27, N UMBER 4, 2011 Immunohematology Volume 27, Number 4, 2011 CONTENTS I N M EMORI A M 117 John J. Moulds G.M. Meny Tribute to John J. Moulds 118 S. Nance, J. Vincent, M.K.G. Moulds, J.M. Moulds, T.S. Casina, and C. Flickinger R EVIEW 131 The ISBT 700 series of low-incidence and 901 series of high- incidence blood group antigens M.E. Reid R EVIEW 136 The LW blood group system: a review M.K.G. Moulds O RIGIN A L R EPORT 143 Occurrence of antibodies to low-incidence antigens among a cohort of multiply transfused patients with sickle cell disease P. Jack son O RIGIN A L R EPORT 146 Determination of optimal method for antibody identification in a reference laboratory J.R. Haywood, M.K.G. Moulds, and B.J. Bryant O RIGIN A L R EPORT 151 Preoperative coagulation studies to predict blood component usage in coronary artery bypass graft surgery S. Josefy, R. Briones, and B.J. Bryant C OMMUNIC ATION 154 Letter from the editors Thank you to the contributors to the 2011 issues 155 A NNOUNCEMENTS 158 A DVERTISEMENTS Index 162 Volume 27, Nos. 1, 2, 3, and 4, 2011 166 I NSTRUCTIONS FOR A UTHORS E DITOR - IN -C HIEF E DITORI A L B OA RD Sandra Nance, MS, MT(ASCP)SBB Philadelphia, Pennsylvania Patricia Arndt, MT(ASCP)SBB Joyce Poole, FIBMS Pomona, California Bristol, United Kingdom M A N AGING E DITOR Cynthia Flickinger, MT(ASCP)SBB James P.
    [Show full text]
  • Blood Group Compatibility
    BLOOD GROUP COMPATIBILITY Blood grouping identifies the ABO and Rh type of a recipient or donor. This grouping ensures that the patient receives compatible blood products. The ABO Blood Group System The ABO blood group is determined by the A or B antigen attached to the membrane of the red blood cell. Group A persons inherit the A antigen and make anti-B antibodies which destroy cells carrying B antigens. Group B persons inherit the B antigen and make anti-A antibodies which destroy cells carrying A antigens. Group AB persons inherit the A and B antigen and do not make either A or B “antibodies”. Group O persons do not inherit the A or B antigen and make “antibodies” which destroy cells carrying A or B antigens. Antibodies against A and B antigens are produced spontaneously in the plasma within the first few months of life. Blood Group Antigen on Red Cell Antibodies in Plasma A A antigen Anti-B B B antigen Anti-A AB both A & B antigens neither Anti-A or Anti-B O neither A & B antigens Anti-A and Anti-B Rhesus (Rh) Blood Group System The Rh type is determined by the presence or absence of the Rh “D” antigen on the red cells. • Rh positive – D antigen is present • Rh negative – D antigen is absent Unlike the ABO system, there are no naturally occurring Rh antibodies. Anti-D is produced when an Rh negative individual is exposed to Rh positive red cells (e.g. through transfusion or pregnancy). Rh antigens are carried on red cells only.
    [Show full text]
  • Prevalence of ABO, Rhd and Other Clinically Significant Blood Group Antigens Among Blood Donors at Tertiary Care Center, Gwalior
    ORIGINAL ARTICLE Bali Medical Journal (Bali Med J) 2020, Volume 9, Number 2: 437-443 P-ISSN.2089-1180, E-ISSN.2302-2914 Prevalence of ABO, RhD and other clinically ORIGINAL ARTICLE significant Blood Group Antigens among blood donors at tertiary care center, Gwalior Published by DiscoverSys CrossMark Doi: http://dx.doi.org/10.15562/bmj.v9i2.1779 Shelendra Sharma, Dharmesh Chandra Sharma,* Sunita Rai, Anita Arya, Reena Jain, Dilpreet Kaur, Bharat Jain Volume No.: 9 ABSTRACT Issue: 2 Background: Among all blood group systems and antigens, ABO and of them 1000 randomly selected donor samples were processed for D antigens of the Rh blood group system are of primary importance, complete Rh, Kell, Duffy and Kidd blood grouping. hence included in routine blood grouping and transfusion. Other blood Result: ABO group pattern was; A - 22.56%, B - 36.52%, AB - 9.8% group systems and antigens that are important in multiparous women, and O -31.12 %, while RhD status was RhD+ 90.99% and RhD- 9.01%. First page No.: 437 multi-transfused patients and hemolytic disease of newborn are Kell, Prevalence of Rh phenotypes was DCCee 43%, DCcee 33%, DCcEe 10%, Rh, Duffy, and Kidd. dccee 6.5%, DccEe 4.5%, Dccee 1%, DCCEe 0.3% and dccEe 0.2%. Aims and Objectives: To know the pattern of ABO, RhD and other Kell phenotype was K-k+ 95.5%, K+k+ 4.5%, while K+ k- and K- clinically significant major antigens of Rh, Kell, Duffy and Kidd blood k- phenotypes were not encountered in this study. Duffy phenotypes P-ISSN.2089-1180 group systems as well as evaluation of phenotypes, genotypes and were Fya+ Fyb+ 47.5%, Fya+ Fyb- 35%, Fya- Fyb+17% and Fya- Fyb- gene frequency of related antigens among blood donors in Gwalior 0.5%.
    [Show full text]
  • Blood Grouping
    WHO GMP ANTISERA CERTIFIED ANTISERA J. MITRA Ensure Your Blood Compatibility with our Product Range... & CO. PVT. LTD. The ABO blood group system is a classification system for the antigens of human blood discovered by Karl Landsteiner in 1900. There are four blood groups : A, B, AB and O. The Rh blood group system is the second most significant system for blood grouping. Rh factor refer to Rh D antigen only. Determination of Rh factor along with ABO is essential for defining the Rh +ve or Rh -ve status of the individual. Around 85% of the human population is Rh +ve while 15% is Rh -ve. The ABO & Rh systems are the most significant blood group systems from the clinical point of view. JML Range of Blood Grouping... Anti-A Monoclonal Anti-B Monoclonal Anti-AB Monoclonal Anti-D (IgM) Rh1 Monoclonal Anti-D (IgG+IgM) Rh1 Monoclonal Anti-H Lectin Anti-A1 Lectin Anti Human Serum Bovine Albumin AANNTTII--HH LLEECCTTIINN AABBOO BBLLOOOODD GGRROOUUPPIINNGG Ulex europaeus lectin for slide and Tube Tests (Anti-A, Anti-B, Anti-AB, Anti-D (IgM) & Anti-D (IgG + IgM) Monoclonal) Anti-H Lectin is used to show the presence of Salient Features: The routine practice of blood typing and cross-matching blood products prevent adverse 'H' antigen on human red blood cells. The 'H' Excellent Avidity antigen is a precursor of A & B antigen. transfusion reactions caused by ABO antibodies. ABO blood grouping is used to check Clearly visible agglutination the RBCs & plasma compatibility of donor and recipient before blood transfusion. Individuals that test as type 'O' by ABO blood Shelf Life : 24 months at 2-8ºC group system may have Bombay Phenotype (hh).
    [Show full text]
  • Safe Blood and Blood Products
    Safe Blood and Blood Products Module 3 Blood Group Serology Safe Blood and Blood Products Module 3 Blood Group Serology Conversion of electronic files for the website edition was supported by Cooperative Agreement Number PS001426 from the Centers for Disease Control and Prevention (CDC), Atlanta, United States of America. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of CDC. © World Health Organization, reprinted 2009 All rights reserved. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; e-mail: [email protected]). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.
    [Show full text]
  • Essentials of Blood Group Antigens and Antibodies
    Essentials of Blood Group Antigens and Antibodies Non-Medical Authorisation of blood Components Nov 2017 East Midlands Regional Transfusion Committee Transfusion Terminology Antigens and Antibodies Antibodies Antigens Blood Group Antigens • Antigens are part of the surface of cells – Red Cells have “Blood group antigens” – White cells and platelets have HLA antigens (platelets also have HPA antigens) https://www.ncbi.nlm.nih.gov/books/NBK2264/bin/imagemap.jpg Reactions to blood usually occurs when the antigen on the donor cells reacts with an antibody in the patient’s plasma What Are Blood Group Antigens? • Complex structures that contain protein and carbohydrate • Part of the membrane structure – blood group antigens often have a role e.g. structural, transport • Produced by inheritance of specific genes – genes produce different antigen options within one blood group system http://en.wikibooks.org/wiki/Structural_Biochemistry/Lipids/Lipid_Bilayer Blood Group Antigens • Currently 36 known blood group systems • Most clinically important are ABO and Rh • Antigens on donor red cells can stimulate a patient to produce an antibody, if the patient lacks the antigen themselves • Likelihood of antibody production is low but increases the more transfusions that are given What are Blood Group Antibodies? • Protein molecules - called https://en.wikipedia.org/wiki/Antibody#/medi a/File:Antibody.svg immunoglobulins (Ig) • Found in the plasma/serum – Produced by the immune system following exposure to a foreign antigen – Antibodies bind specifically
    [Show full text]
  • A Study to Find out Association Between Blood Group and Platelet Count
    National Journal of Physiology, Pharmacy and Pharmacology RESEARCH ARTICLE A study to find out association between blood group and platelet count Nileshwari H Vala, Gitesh J Dubal Department of Physiology, Shri M. P. Shah Government Medical College, Jamnagar, Gujarat, India Correspondence to: Gitesh J Dubal, E-mail: [email protected] Received: October 28, 2018; Accepted: November 18, 2018 ABSTRACT Background: Blood group antigens are protein structure on red blood cell membrane, and platelet has receptors on its surface for binding which are also protein in nature. Aims and Objectives: Thus, some genetic association for certain blood group types with platelet function and count can shade some light in this area of research. Materials and Methods: A total of 51 cases were included in the present study. All healthy male and female subjects above 18 years were included in our study. Prior Indian Ethics Committee approval was taken, and information sheet was provided about the present study and only when voluntary consent subjects’ 0.5 ml venous blood was collected aseptically. Basic information about name, age, and gender was collected. Platelet count was calculated using an autoanalyzer instrument. Data analysis was done using MedCalc v18.6 software. P < 0.05 was considered significant. Results: Out of 51 cases the majority of subjects were A positive and B positive with 16 in each case. Highest platelet count was found in B positive blood group at 241562 ± 69970. Lowest platelet count was found in AB positive blood group at 216142 ± 51689. Conclusion: On applying single factor ANOVA for finding out the association between platelet count and blood group, P value was present at 0.934.
    [Show full text]
  • Blood Grouping Reagent IH-Card ABO/D(DVI-)+Rev A1, B A-B-D(DVI-)-Ctl-Neutral-Neutral
    Blood Grouping Reagent IH-Card ABO/D(DVI-)+Rev A1, B A-B-D(DVI-)-ctl-Neutral-Neutral English, B186350, Version 05, 2016.07 FOR IN VITRO DIAGNOSTIC USE Gel card for use with the IH-System MEETS FDA POTENCY REQUIREMENTS U.S. License Number: 1845 Product-Identification: 71000 IH-Card ABO/D(DVI-)+Rev A1, B: VOL12 cards per box REF 813 110 100 VOL 48 cards per box REF 813 111 100 VOL 288 cards per box REF 813 112 100 INTENDED USE The IH-Card ABO/D(DVI-)+Rev A1, B is intended for the performance of forward and reverse ABO grouping and D (RH1) antigen typing of human red blood samples using the IH-System. SUMMARY Between 1900 and 1902, Karl Landsteiner and associates discovered the ABO system of red blood cell antigens. The importance of this discovery is the recognition that antibodies are present when the corresponding antigens are lacking. The ABO system is the only blood group system in which the reciprocal antibodies are consistently and predictably present in most people. Due to this reciprocity, a blood type determination is considered valid if serum grouping corresponds with red blood cell grouping.1 ABO blood group typing, using Anti-A and Anti-B antisera to detect the A (ABO1) and B (ABO2) antigens, is known as direct or forward grouping. Reverse grouping (serum grouping test) uses Reagent Red Blood Cells of known ABO antigen specificity to indicate the presence or absence of anti-A and anti-B antibodies. Discrepancies between forward and reverse grouping require further investigation.
    [Show full text]
  • Immunohematology Vol 21, #4
    D DDD D DDD D D D DDD D DDD D D ImmunohematologyD D D D JOURNALDD OF BLOOD GROUP SEROLOGYDD AND EDUCATION D D DDD D DDD D DDD D DDD D D D DDD D DDD D DDD D DDD D D D DDD D DDD D DDD D DDD D D D DDV OLUMED 21, NUMBER 4,D 2005 D D D Immunohematology JOURNAL OF BLOOD GROUP SEROLOGY AND EDUCATION VOLUME 21, NUMBER 4, 2005 CONTENTS 141 Review: the Rh blood group system: an historical calendar P. D . I SSITT 146 Reactivity of FDA-approved anti-D reagents with partial D red blood cells W. J. J UDD,M.MOULDS,AND G. SCHLANSER 149 Case report: immune anti-D stimulated by transfusion of fresh frozen plasma M. CONNOLLY,W.N.ERBER,AND D.E. GREY 152 Incidence of weak D in blood donors typed as D positive by the Olympus PK 7200 C.M. JENKINS, S.T. JOHNSON, D.B. BELLISSIMO,AND J.L. GOTTSCHALL 155 Review: the Rh blood group D antigen . dominant, diverse, and difficult C.M.WESTHOFF 164 COMMUNICATIONS Letters from the editors Ortho-Clinical Diagnostics sponsorship Thank you to contributors to the 2005 issues 166 168 Letters from the outgoing editor-in-chief Letter from the incoming editorial staff Thank you with special thanks to Delores Changing of the guard 169 IN MEMORIAM John Maxwell Bowman, MD; Professor Sir John V.Davies, MD;Tibor J.Greenwalt, MD; and Professor J.J.Van Loghem 174 176 177 ANNOUNCEMENTS UPCOMING MEETINGS ADVERTISEMENTS 180 INSTRUCTIONS FOR AUTHORS 181 INDEX — V OLUME 21, NOS.
    [Show full text]